Bristol-Myers Squibb India Private Limited, a active foreign private limited company, was established on 30 June 2004 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2004FTC147232. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹350.00 Cr and a paid-up capital of ₹346.91 Cr.
It upholds a compliant status. Its leadership includes Sanjay Sharma (Director), Harsh Atul Mehta (Additional Director), Anuradha Gupta (Additional Director). Past directors included Mark Christopher Trudeau, Mukesh Surendra Agarwal, Francoise Pierre Perret. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at One International Center, 6Th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai, Maharashtra, 400013.
U24230MH2004FTC147232
147232
30 June 2004
₹350.00 Cr
₹346.91 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bristol-Myers Squibb India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Sharma | Director | 24 May 2022 | Current |
| Harsh Atul Mehta | Additional Director | 06 May 2025 | Current |
| Anuradha Gupta | Additional Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Nov 2009 | Past |
| Pramod Abcsdd | Additional Director | 31 Oct 2012 | Past |
| Pramod Abcsdd | Director | 11 Nov 2009 | Past |
| Pramod Abcsdd | Director | 01 Aug 2008 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bristol-Myers Squibb India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.72% increase. The company also saw a substantial improvement in profitability, with a 327.6% increase in profit. The company's net worth Soared by an impressive increase of 22.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bristol-Myers Squibb India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bristol-Myers Squibb India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bristol-Myers Squibb India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bristol-Myers Squibb India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Harsh Atul Mehta was appointed as a Additional Director was appointed as a Additional Director on 06 May 2025 & has been associated with this company since 6 months 25 days . was recorded as a recent event.
Anuradha Gupta was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 7 months 29 days . was recorded as a recent event.
The activity Bristol-Myers Squibb India Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Bristol-Myers Squibb India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Sanjay Sharma was appointed as a Director was appointed as a Director on 24 May 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The activity Narendra Mundra was appointed as a Company Secretary was appointed as a Company Secretary on 23 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
The CIN of Bristol-Myers Squibb India Private Limited is U24230MH2004FTC147232.
Bristol-Myers Squibb India Private Limited is headquartered at One International Center, 6Th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai, Maharashtra, 400013.
Bristol-Myers Squibb India Private Limited was incorporated on 30 June 2004.
The current directors of Bristol-Myers Squibb India Private Limited are
The primary industry of Bristol-Myers Squibb India Private Limited is Trade.
Bristol-Myers Squibb India Private Limited is unlisted.
The authorized capital of Bristol-Myers Squibb India Private Limited is ₹350.00 Cr, and the paid-up capital is ₹346.91 Cr.
The compliance status of Bristol-Myers Squibb India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX